These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6665480)

  • 1. [How to prescribe and monitor treatment with hypolipidemic drugs].
    Basdevant A; Soffer M
    Rev Prat; 1983 Nov; 33(54):2967-71. PubMed ID: 6665480
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acipimox treatment of hyperlipidemia type II].
    Noseda G; Fragiacomo C; Cairoli R
    Schweiz Med Wochenschr; 1982 Dec; 112(49):1790-1. PubMed ID: 6758114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experimentation of clofibride. Apropos of 40 cases].
    Warembourg H; Jaillard J
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1292-6. PubMed ID: 4802928
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hyperlipidemia, coronary disease and antilipemic drugs--do they help?].
    Hansteen V
    Tidsskr Nor Laegeforen; 1995 Nov; 115(29):3602-3. PubMed ID: 8539711
    [No Abstract]   [Full Text] [Related]  

  • 5. Study of mepartricin possible interactions with antilipemic drugs. Controlled clinical trials in patients with benign prostatic hyperplasia.
    Piccinno A; Cirillo Marucco E; Ludovico GM; Pagliarulo A
    Panminerva Med; 1990; 32(3):122-5. PubMed ID: 1706493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs for lipid disorders.
    Treat Guidel Med Lett; 2003 Aug; 1(12):77-82. PubMed ID: 15529095
    [No Abstract]   [Full Text] [Related]  

  • 7. [Determination of the dose-response curve of a new hypolipidemic molecule: tibric acid (CP-18524). Methodologic and statistical aspects].
    Bielmann P; Annable L; Brun D; Moorjani S; Lupien PJ; Tétreault L
    Union Med Can; 1975 Jun; 104(6):930-4. PubMed ID: 1224412
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of drug therapy in hyperlipidemia in patients after myocardial infarct in the Czech Republic].
    Widimský J; Lánská V; Jurán F; Leisser J; Vanĕk P; Spírek A; Koval Z
    Vnitr Lek; 1997 Apr; 43(4):191-4. PubMed ID: 9601832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypolipidemic action of simfibrate in diabetic subjects].
    Gragnoli G; Tanganelli I; Signorini AM; Kristodhullu A
    Clin Ter; 1981 Feb; 96(4):397-408. PubMed ID: 7214862
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeting vascular risk in patients with metabolic syndrome but without diabetes.
    Athyros VG; Mikhailidis DP; Papageorgiou AA; Didangelos TP; Peletidou A; Kleta D; Karagiannis A; Kakafika AI; Tziomalos K; Elisaf M
    Metabolism; 2005 Aug; 54(8):1065-74. PubMed ID: 16092057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug therapy of hyperlipidemias].
    Wolfram G
    Wien Med Wochenschr; 1981; 131(13-14):333-8. PubMed ID: 7281700
    [No Abstract]   [Full Text] [Related]  

  • 12. Does the treatment of dyslipidemia affect the risk of depression or suicidal behaviour?
    Juurlink DN
    CMAJ; 2004 Jan; 170(2):192. PubMed ID: 14734431
    [No Abstract]   [Full Text] [Related]  

  • 13. [How sure is the combined lipid lowering?].
    Schäfer J
    MMW Fortschr Med; 2005 Jan; 147(1-2):56. PubMed ID: 15704576
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug therapy of hyperlipidemia--unanswered questions].
    Tonstad S
    Tidsskr Nor Laegeforen; 1997 Feb; 117(5):674-7. PubMed ID: 9102959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing drug usage and adverse effects. Part III: Cardiovascular disease and hyperlipidemia.
    Baron M
    Health Care Food Nutr Focus; 2005 Jun; 22(6):7-11. PubMed ID: 15923907
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience with crystalline niacin as the preferred drug for dyslipidemia in a specialty clinic.
    Rindone JP; Arriola OG
    Pharmacotherapy; 1997; 17(6):1296-9. PubMed ID: 9399614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The current situation of therapy in hyperlipemias].
    Vallina Alvarez E; Arribas Castrillo JM; Suárez García E
    An Med Interna; 1990 Jul; 7(7):370-4. PubMed ID: 2103252
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug interactions and side effects of hypolipidemic drugs.
    Schwandt P
    Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):351-6. PubMed ID: 489202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating lipid-lowering trials in the twenty-first century.
    Roberts WC
    Am J Cardiol; 2009 May; 103(9):1325-8. PubMed ID: 19406281
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antihyperlipidemic actions in the treatment of nephropathies].
    Neverov NI; Tareeva IE; Miroshnichenko NG; Stavrovskaia EV
    Ter Arkh; 1995; 67(8):15-7. PubMed ID: 7482321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.